Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma.
Glypican-3 (GPC3) is a cell-surface heparan sulfate proteoglycan highly expressed in hepatocellular carcinoma (HCC). We have generated a group of high-affinity mouse monoclonal antibodies targeting GPC3. Here, we report the humanization and testing of these antibodies for clinical development. We compared the affinity and cytotoxicity of recombinant immunotoxins containing mouse single-chain variable regions fused with a Pseudomonas toxin. To humanize the mouse Fvs, we grafted the combined KABAT/IMGT complementarity determining regions (CDR) into a human IgG germline framework. Interestingly, we found that the proline at position 41, a non-CDR residue in heavy chain variable regions (VH), is important for humanization of mouse antibodies. We also showed that two humanized anti-GPC3 antibodies (hYP7 and hYP9.1b) in the IgG format induced antibody-dependent cell-mediated cytotoxicity and complement-dependent-cytotoxicity in GPC3-positive cancer cells. The hYP7 antibody was tested and showed inhibition of HCC xenograft tumor growth in nude mice. This study successfully humanizes and validates high affinity anti-GPC3 antibodies and sets a foundation for future development of these antibodies in various clinical formats in the treatment of liver cancer.
Antibody Therapy Section, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
Yi-Fan
YF
Zhang
Antibody Therapy Section, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
Mitchell
M
Ho
FEBS Lett. 2015 Jan 16;589(2):193-200
25481411
Sci Rep. 2015 May 21;5:9928
25996440
Clin Cancer Res. 2013 Feb 15;19(4):920-8
23362325
Ann Surg Oncol. 2014 Apr;21(4):1405-11
24499827
Hepatology. 2014 Aug;60(2):576-87
24492943
PLoS One. 2012;7(3):e32212
22403636
FEBS J. 2006 May;273(10):2184-94
16649995
Nat Commun. 2015 Mar 11;6:6536
25758784
Immunobiology. 2011 Dec;216(12):1239-47
21802167
PLoS One. 2011 Jan 31;6(1):e16373
21305012
Clin Cancer Res. 2013 Aug 15;19(16):4433-45
23812669
J Mol Biol. 2010 Apr 30;398(2):214-31
20226193
Gastroenterology. 2003 Jul;125(1):89-97
12851874
J Mol Biol. 1995 Oct 27;253(3):385-90
7473721
Lancet Oncol. 2016 Jun;17(6):e254-e262
27299281
PLoS One. 2012;7(9):e45595
23049820
J Biol Chem. 2013 Mar 15;288(11):7688-7696
23355464
PLoS One. 2013 May 22;8(5):e63906
23717507
Cancer Res. 2005 Jul 15;65(14):6245-54
16024626
Protein Eng Des Sel. 2010 Dec;23(12):947-54
21037278
MAbs. 2011 Jul-Aug;3(4):376-86
21540647
Proteins. 2012 Mar;80(3):896-912
22180101
MAbs. 2012 Sep-Oct;4(5):592-9
22820551
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1083-91
23471984
J Pediatr Hematol Oncol. 2001 Nov;23(8):496-9
11878776
Oncoimmunology. 2012 Jul 1;1(4):477-486
22754766
Int Immunopharmacol. 2014 Feb;18(2):304-10
24370392
PLoS One. 2015 Sep 21;10(9):e0137345
26390038
Int J Cancer. 2011 May 1;128(9):2020-30
20635390
Protein Eng Des Sel. 2009 Mar;22(3):175-88
19022801
J Biol Chem. 2015 Dec 11;290(50):30018-29
26487718
ACS Chem Biol. 2012 Jun 15;7(6):1049-58
22458453
Clin Cancer Res. 2013 Mar 1;19(5):1126-38
23209031
Cancer Immunol Immunother. 2012 Jul;61(7):953-62
22527245
Proteins. 2009 Feb 1;74(2):497-514
19062174
Mod Pathol. 2008 May;21(5):626-31
18264086
Biochem Biophys Res Commun. 2009 Jan 9;378(2):279-84
19022220
Biochem Biophys Res Commun. 2009 Feb 6;379(2):314-8
19103171
Mol Cancer Ther. 2012 Nov;11(11):2451-61
22869555
FEBS J. 2012 Jan;279(2):223-33
22074399
Cell Rep. 2016 May 17;15(7):1505-1513
27160908
Protein Expr Purif. 2014 Oct;102:45-51
25088934
PLoS One. 2015 Sep 02;10(9):e0137664
26332121
Histol Histopathol. 2008 Nov;23(11):1333-40
18785116
Eur J Cancer. 2011 Feb;47(3):333-8
21112773
J Immunol. 2012 Nov 15;189(10):4890-9
23066154
Mol Immunol. 2010 Jan;47(4):816-24
19864027
J Mol Biol. 1994 Apr 29;238(2):226-44
8158652
Front Immunol. 2013 Oct 08;4:302
24115948
Vaccine. 2009 Apr 14;27(17):2356-66
19428851
J Exp Med. 1970 Aug 1;132(2):211-50
5508247
FEBS J. 2009 Aug;276(15):4207-22
19558491
Mol Biotechnol. 2010 Nov;46(3):265-78
20556545
Nature. 1986 May 29-Jun 4;321(6069):522-5
3713831
Protein Eng Des Sel. 2009 Mar;22(3):135-47
19188138
Neoplasia. 2011 Aug;13(8):735-47
21847365